Literature DB >> 21416194

Orthopaedic management of Hurler's disease after hematopoietic stem cell transplantation: a systematic review.

Marleen H van der Linden1, Moyo C Kruyt, Ralph J B Sakkers, Tom J de Koning, F Cumhur Oner, René M Castelein.   

Abstract

OBJECTIVE: The introduction of hematopoietic stem cell transplantation (HSCT) has significantly improved the life-span of Hurler patients (mucopolysaccharidosis type I-H, MPS I-H). Yet, the musculoskeletal manifestations seem largely unresponsive to HSCT. In order to facilitate evidence based management, the aim of the current study was to give a systematic overview of the orthopaedic complications and motor functioning of Hurler's patients after HSCT.
METHODS: A systematic review was conducted of the medical literature published from January 1981 to June 2010. Two reviewers independently assessed all eligible citations, as identified from the Pubmed and Embase databases. A pre-developed data extraction form was used to systematically collect information on the prevalence of radiological and clinical signs, and on the orthopaedic treatments and outcomes.
RESULTS: A total of 32 studies, including 399 patient reports were identified. The most frequent musculoskeletal abnormalities were odontoid hypoplasia (72%), thoracolumbar kyphosis (81%), genu valgum (70%), hip dysplasia (90%) and carpal tunnel syndrome (63%), which were often treated surgically during the first decade of life. The overall complication rate of surgical interventions was 13.5%. Motor functioning was further hampered due to reduced joint mobility, hand dexterity, motor development and longitudinal growth.
CONCLUSION: Stem cell transplantation does not halt the progression of a large range of disabling musculoskeletal abnormalities in Hurler's disease. Although prospective data on the quantification, progression and treatment of these deformities were very limited, early surgical intervention is often advocated. Prospective data collection will be mandatory to achieve better evidence on the effect of treatment strategies.

Entities:  

Mesh:

Year:  2011        PMID: 21416194      PMCID: PMC3109254          DOI: 10.1007/s10545-011-9304-x

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


Introduction

Hurler’s disease (mucopolysaccharidosis type I, MPS I-H) is an autosomal recessive lysosomal storage disease with an estimated incidence of about 1/ 100,000 (Malm et al. 2008b). The disorder is caused by a deficiency of the enzyme α-L-iduronidase (IDUA), leading to the cellular accumulation of the glycosaminoglycans (GAGs) dermatan and heparan sulphate. This cellular accumulation, in turn, leads to progressive and generalised cell, tissue and organ dysfunction. If left untreated, patients will die early of cardiopulmonary failure (median age 6.8 years) (Moore et al. 2008). In addition, patients will develop progressive mental retardation, corneal clouding, hepatosplenomegaly and dysostosis multiplex (Cleary and Wraith 1995). Dysostosis multiplex refers to a broad constellation of skeletal abnormalities such as a thickened skull, shortened long bones, odontoid hypoplasia, vertebral abnormalities, acetabular dysplasia, genu valgum and short/ broad digits (Aldenhoven et al. 2009). These abnormalities presumably arise from a lack of primary ossification at several predeliction sites, a lack of secondary bone remodelling, and dysfunction of ligamentous structures and joint capsules (Field et al. 1994). Histological examination of growth plates revealed swollen vacuole-filled chondrocytes, architectural irregularities, and failure of cartilage mineralization (Silveri et al. 1991). The exact pathophysiological mechanism underlying the bony abnormalities in Hurler’s disease remains unclear, however. The introduction of hematopoietic stem cell transplantation (HSCT) in 1981 by Hobbs has significantly improved the survival and disease progression of Hurler patients (Hobbs 1981). Following successful engraftment, the donor cells provide a natural source of the deficient enzyme, which results in improved cardiopulmonary symptoms, decreased hepatosplenomegaly and an improved neurodevelopmental status (Peters and Steward 2003; Souillet et al. 2003; Hugh-Jones 1986). As a result, treated patients now survive into adulthood. Yet, the majority of the musculoskeletal problems seem largely unresponsive to HSCT, presumably due to insufficient penetration of the donor enzyme in the skeletal tissues (Breider et al. 1989). Due to the increased life expectancy of Hurler patients, and the limited response of their musculoskeletal abnormalities to HSCT, orthopaedic problems become relevant in the follow-up of these patients. The majority of Dutch Hurler patients are treated at our institution, and orthopaedic questions regarding the optimal treatment of these disabling musculoskeletal abnormalities have accumulated. Although the literature and the worldwide MPS I registry (Pastores et al. 2007) provide some answers, a systematic overview of the prevalence, clinical course and treatment of the various orthopaedic manifestations of Hurler’s disease is currently lacking. Therefore, the objective of this study was to provide a systematic review on the musculoskeletal manifestations of Hurler’s disease after HSCT, with emphasis on the orthopaedic treatment and outcome. Additionally, information on aspects of motor functioning such as gait/mobility, motor skills, joint range of motion and longitudinal growth was systematically collected.

Methods

Search strategy

An electronic search of the literature published from January 1981 to June 2010 was conducted in Pubmed and Embase, by using MeSH (Medical Subject Heading, Medline) and EMBASE terms, as well as free text words. The search included the terms Hurler, mucopolysaccharidosis type I, MPS I, iduronidase deficiency, orthopaedic, orthopedic, dysostosis multiplex, musculoskeletal, hip, spine, knee, joint, bones, myelopathy, kyphosis, genu valgum, carpal tunnel syndrome, trigger finger, odontoid, growth, height and motor development. Two reviewers (MV and MK) independently assessed the titles and abstracts of all eligible citations to determine if they met the inclusion criteria. Selected articles were then evaluated in full text by the same two reviewers. Additional articles were sought by reference tracking. Disagreements were resolved by means of discussion.

Inclusion and exclusion criteria

The search strategy was confined to patients with Hurler’s disease after hematopoietic stem cell transplantation (HSCT) in combination with a description of the musculoskeletal manifestations and/or the topics: gait, motor skills, joint range of motion (ROM), longitudinal growth and neurological symptoms. Only original articles published after 1981 were selected (the introduction of HSCT for MPS by Hobbs (Hobbs 1981)). All languages were included. Case reports and selected patient populations were reviewed for treatment options only. Papers were excluded if patients were not treated with HSCT, or if we remained unsure about previous HSCT after contacting the authors.

Data extraction

A pre-developed data extraction form was used to systematically collect all relevant information from the articles. All data were scored in relation to the patient’s age and duration of follow-up after HSCT. The orthopaedic aspects contained the radiological and clinical signs of spinal involvement, hip dysplasia, genu valgum, carpal tunnel syndrome and trigger fingers. In addition, all available information on orthopaedic treatments and outcomes was collected. A surgical complication or adverse outcome was defined as the need for a re-operation, a correction that was judged insufficient by the authors (e.g. tibio-femoral angle >7°, Odunusi et al. 1999), or the absence of an objective improvement in disease symptoms.

Data analysis

The average prevalence of the radiological and clinical signs of Hurler’s disease was calculated by pooling all reported cases per topic (so called patient reports). In addition, weighted averages of the age at HSCT and duration of follow-up after HSCT were calculated. A similar method was used to pool all data on treatment options and outcome. The number of reports that were available for the calculation of the average age at HSCT and follow-up after HSCT was usually somewhat smaller compared to the number of available reports on prevalence (data not shown). For the prevalence data, only papers on non-selected patient cohorts were included. As a consequence, five papers were excluded from this analysis; three on CTS (17 patients referred for CTS diagnostics), one on kyphosis (one patient referred for anterior fusion) (Dalvie et al. 2001), and one on linear growth (eight patients treated with growth hormone therapy) (Polgreen et al. 2009). When reviewing the included articles, 5 studies stated that similar patients were included in multiple papers. The number of patients that were reported twice ranged from 2–6. Yet, the topics and duration of follow-up differed across the studies. All other included papers were analysed for potential patient overlap as well. As shown in Table 1, a large number of studies originated from a limited number of institutions. After careful comparison, no more than two papers with potential patient overlap per topic were identified. Because these papers contained unique and relevant data, all selected patient reports were included for further evaluation.
Table 1

Institutes at which the included studies were conducted

Origin of included studiesTotal number of articlesTotal number of patients
University of Minnesota, Minneapolis, U.S.A.8210
University of North Carolina, Chapel Hill, U.S.A341
Westminster Children’s Hospital, London, U.K.317
Our Lady`s Hospital for Sick Children, Dublin, Ireland231
Royal Manchester Children’s Hospital, Manchester, U.K.222
Hôpital Debrousse, Lyon, France220
Karolinska University Hospital, Stockholm, Sweden210
Children’s Hospital and Franciscan Hospital for children, Boston, U.S.A.22
Duke University Medical Center, Durham, U.S.A.117
University of Kentucky Medical Center, Lexington, U.S.A.111
University of California, San Francisco, U.S.A.17
Children’s Hospital, Hannover Medical School, Hannover, Germany15
Children’s Hospital, North Adelaide, Australia13
Hôpital Neurologique, Lyon, France11
University of Western Ontario, London, Canada11
Pellenberg University Hospital, Lubbeek, Belgium11
Total32399
Institutes at which the included studies were conducted

Results

Description of studies

A total of 32 studies (31 case series and one case report) published between 1993 and 2009 were included (see Fig. 1 for flow chart and Table 2). These studies described a total of 399 patient reports. The vast majority of studies (29) were longitudinal and of retrospective nature. A total of 26 studies described only Hurler patients, the other six studies described mixed patient populations. The average age of the patients at HSCT was 18.8 ± 7.0 months (25 studies, n = 348 patients, range across studies 13–48 months). The average duration of follow-up was 73.3 ± 35.4 months after HSCT (23 studies, n = 321 patients, range across studies 10.5-134.4 months). The donor source that was used for HSCT treatment was described by 16 studies; eight had included multiple donor types, four used cord blood transplantations only, three were confined to unrelated donors, and one to related donors. The success rate of HSCT was described by 14 papers, with full engraftment at the first attempt in on average 76% of the cases (range 47-100%). In the following sections, the motor functioning/ longitudinal growth and musculoskeletal manifestations of Hurler’s disease will be addressed separately (section 3.2 and 3.3 respectively). Note that prevalence data were calculated based on subgroup analyses, with average group sizes of 55 patients (range 21–107) for motor functioning (Table 3A), 48 (range 7–103) for the musculoskeletal manifestations (Table 3B), and 88 (range 7–170) for the surgical interventions (Table 3C).
Fig. 1

Flow chart of included studies

Table 2

Specifications of the included articles

Year of publicationFirst authorNumber of Hurler patientsAge at HSCT (months)Follow up since HSCT (months)Major topics
1986Hugh-Jones519.637.8Kyphosis, gait, hand dexterity, joint ROM, growth
1993Belani30C1-2 instability, odontoid dysplasia, cord compression, neurological symptoms
1993Hopwood313> 120Kyphosis, hip dislocation, genu valgum, CTS, gait, joint ROM and surgical procedures *
1994Bona1CTS (surgery)
1994Field1119.5111Kyphosis, hip dysplasia, genu valgum, CTS, joint ROM, growth and surgical procedures
1996Masterson8928Hip dysplasia (surgery), gait
1996Tandon121654C1-2 instability, odontoid dysplasia, soft tissue deposition, cord compression, vertebral abnormalities, kyphosis (surgery), scoliosis, disc abnormalities, spondylolisthesis, neurological symptoms
1997Vellodi1017134.4C1-2 instability, odontoid hypoplasia, soft tissue deposition, cord compression, kyphosis, hip dysplasia, gait, motor development, hand dexterity, growth and surgical procedures
1998Flemming112060Joint ROM
1998Guffon960Kyphosis, hip dysplasia, genu valgum, CTS, joint ROM, growth and surgical procedures
1998van Heest1521CTS and trigger finger surgery
1999Odunusi1719Genu valgum (surgery)
2000Hite820104.4Odontoid hypoplasia, soft tissue deposition, cord compression
2000Kachur12472Cord compression (surgery), soft tissue deposition, kyphosis, genu valgum, neurological symptoms, hand dexterity, muscle strength
2001Dalvie14812Kyphosis (surgery)
2003Souillet1124.290C1-2 instability, kyphosis, scoliosis, genu valgum, hip dysplasia, CTS, joint ROM, muscle strength, growth and surgical procedures
2004Dumas1Gait, motor development
2004Staba171854Kyphosis, growth and surgical procedures
2004Weisstein72055.2C1-2 instability, soft tissue deposition, vertebral and disc abnormalities, kyphosis, hip dysplasia, genu valgum, CTS and trigger fingers, neurological symptoms, hand dexterity, joint ROM and surgical procedures
2005Dusing222.510.5Motor development, hand dexterity, kyphosis, hip dislocation
2005van Meir1CTS and kyphosis surgery
2006Bjoraker4121.767.2Motor development
2006Ringdén4< 20Kyphosis (surgery), hip dislocation, gait, neurological symptoms
2007Dusing2117.116.2Motor development, genu valgum
2007Dusing1818.829.9Gait
2007Khanna4319103.2CTS (surgery)
2007Lucke52546Motor development, hand dexterity
2008Malm61867.2Hip dysplasia, CTS, neurological symptoms, hand dexterity, growth and surgical procedures
2008Polgreen482083Growth
2008Taylor239.4102Kyphosis, scoliosis, genu valgum, hip dysplasia, gait, joint ROM, muscle strength, growth and surgical procedures
2009Polgreen8Kyphosis, genu valgum and surgical procedures
2009Rebello1Hip dysplasia (surgery)

HSCT = hematopoietic stem cell transplantation, ROM = range of motion, CTS = carpal tunnel syndrome

* Surgical procedures are not further specified in the current table

Table 3

A, B, C. Motor functioning, musculoskeletal manifestations, and surgical interventions in Hurler’s disease after HSCT treatment

TopicTotal number of papersTotal number of patientsAffected patients N (%)Age at HSCT (months)Follow-up after HSCT (months)
A. Motor functioning
Gait / mobility981*
Unaided, independent gait64912 (24.5)20.072.6
ROMhip, knee, shoulder, elbow75552 (94.5)20.692.0
Longitudinal growth9107*
Growth < −2SD of normal55830 (51.7)20.080.2
Sitting height/ trunk growth221*
Motor development563*
Hand dexterity72623 (88.5)20.850.1
Neurological symptoms76112 (19.7)20.648.5
Muscle strength345*
B. Musculoskeletal manifestations
I. Radiological signs
X-ray of cervical spine
C1-2 instability57014 (20.0)19.284.2
Odontoid hypoplasia46043 (71.7)17.494.2
MRI of cervical spine
Soft tissue deposition around odontoid52824 (85.7)17.997.8
Spinal cord compression5594 (6.8)18.8100.0
Ligamentous hypertrophy3196 (31.6)20.1107.7
X-ray or MRI of thoracolumbar spine
Vertebral abnormalities33028 (93.3)18.275.2
Kyphosis1410182 (81.2)16.680.0
Scoliosis34615 (32.6)14.786.6
Spondylolisthesis11210 (83.3)16.054.0
Disc abnormalities2103 (30.0)16.854.2
X-knee
Genu valgum910372 (69.9)16.474.2
Dysplasia of proximal tibial metaphysis23423 (67.6)12.7104.9
X-hip
Hip dysplasia86760 (89.6)15.484.4
Hip dislocation/ (sub)luxation83213 (40.6)14.454.5
II. Hand involvement
Carpal tunnel syndrome79057 (63.3)18.490.7
Trigger fingers174 (57.1)20.055.2
C. Surgical interventions
Treatment
Cervical fusion5455 (11.1)20.697.2
Spinal cord decompression2173 (17.6)18.2101.8
Thoracolumbar spinal fusion1417055 (32.4)16.586.2
Knee surgery814051 (36.4)16.080.0
Hip containment surgery910146 (45.5)16.184.2
Carpal tunnel release1214179 (56.0)19.193.2
Trigger finger release174 (57.1)20.055.2

HSCT = hematopoietic stem cell transplantation, ROM = range of motion, SD = standard deviation

* = limited data available on the number of affected patients; available group data will be discussed in the results section

Flow chart of included studies Specifications of the included articles HSCT = hematopoietic stem cell transplantation, ROM = range of motion, CTS = carpal tunnel syndrome * Surgical procedures are not further specified in the current table

Motor functioning and longitudinal growth of Hurler patients after HSCT

With increasing life expectancy in Hurler’s disease, recent research activities have focussed their attention on everyday functioning. Gait and independent mobility are important aspects of everyday motor functioning. A total of nine studies, including 81 patients investigated gait in Hurler’s disease (see also Table 3A). All of these studies addressed one of three aspects of gait: 1) development of independent walking in toddlers, 2) quality of gait, and 3) independent gait and mobility in late childhood/ adolescence. With respect to independent walking, four studies reported a delayed onset (Hugh-Jones 1986; Dusing et al. 2007a; Ringden et al. 2006; Dusing et al. 2007b). This developmental delay was attributed to limited practice during hospitalisation for HSCT, in addition to orthopaedic abnormalities (Dusing et al. 2007a). The second aspect of gait, quality of gait, has recently been addressed by Dusing et al. in a group of 18 patients (Dusing et al. 2007a). The patients had reduced walking speed, shortened step length, and increased energy expenditure early in life. Yet, walking speed and step length normalised by the age of 4 years. The third aspect of gait concerned the preservation of independent gait (see also Table 3A). While the majority of patients remained mobile, independent unaided gait was lost in 12 patients (24.5%), at a mean follow-up of 72.6 months after HSCT, predominantly due to orthopaedic complications such as severe genu valgum and hip dislocation. A, B, C. Motor functioning, musculoskeletal manifestations, and surgical interventions in Hurler’s disease after HSCT treatment HSCT = hematopoietic stem cell transplantation, ROM = range of motion, SD = standard deviation * = limited data available on the number of affected patients; available group data will be discussed in the results section Other aspects that contribute to motor functioning are the development of gross and fine motor skills. These were generally studied on a group level, using developmental scales such as the Vineland Adaptive Behavior Scales (VABS) (Bjoraker et al. 2006), Peabody Developmental Motor Scales, edition 2 (PDMS-2) (Dusing et al. 2007a; Dusing et al. 2007b; Dusing et al. 2005), Denver Developmental Screening Test (DDST) (Lucke et al. 2007), and the more recently developed MPS-PPM (MPS physical performance measure) (Dumas et al. 2004). Evaluation of these five studies, including a total of 63 patients, showed that Hurler patients were limited in their gross motor development and had mild to pronounced motor retardation between 0 and 4 years of age, when compared to age-referenced controls. However, the limitations in a group of 41 treated Hurler patients were milder as compared to a cross-sectional group of 43 non-treated patients (Bjoraker et al. 2006). Not surprisingly, the degree of motor development was associated with the age and developmental status of the patients at the time of HSCT, such that the younger and less affected patients had a better developmental outcome (Bjoraker et al. 2006). On the topic of fine motor skills, specifically hand dexterity, individual patient data were available (see Table 3A). Although age-referenced hand function improved after HSCT treatment (Hugh-Jones 1986; Lucke et al. 2007), 88.5% of the patients still showed impairments in comparison to healthy children. These impairments were partly caused by comorbidities such as CTS (Malm et al. 2008b), trigger fingers (Weisstein et al. 2004) and spinal cord compression (Kachur and Del Maestro 2000), and for the other part by bony abnormalities such as broad stubby digits. Limitations in joint range of motion (ROM), especially of the upper extremity, were another main feature of Hurler’s disease (prevalence 94.5%, see Table 3A). Although positive effects of HSCT on joint ROM were consistently reported, joint mobility in treated Hurler patients remained limited (Field et al. 1994; Hugh-Jones 1986; Weisstein et al. 2004; Fleming et al. 1998; Guffon et al. 1998). Fixed flexion contractures of the lower extremity were occasionally reported in the older literature, when surgical interventions of progressive hip subluxation and genu valgum were postponed (Field et al. 1994). Although some authors have optimistically reported normalised longitudinal growth following HSCT (Hugh-Jones 1986), growth rates appeared compromised at long term follow-up. A total of nine studies, including 107 patients, have reported growth details. A height below 2SD of the average is generally considered abnormal. Information on the number of patients shorter than -2SD was provided by 58 patient reports. A total of 51.7% of these patients had short stature, with a mean follow-up of 80.2 months after HSCT. The linear growth of Hurler patients was associated with the age at HSCT (Souillet et al. 2003; Polgreen et al. 2008; Vellodi et al. 1997), such that a younger age at HSCT resulted in a larger height. High enzyme levels following HSCT, and conditioning regimens for HSCT without total body irradiation were also associated with a larger height (Polgreen et al. 2008). In general, the growth rate of Hurler patients remained normal for several years, after which it gradually decreased. For example, Vellodi et al. showed that the average height of 10 patients reached -2SD at an age of 6 years (Vellodi et al. 1997). The decreased growth was largely attributable to a reduced trunk growth with an average sitting height below 3SD at 8 years of age, and below 4SD at 12 years of age (corresponding subischial leg length of 0 SD and – 2 SD respectively). Motor functioning in Hurler’s disease was further compromised by neurological comorbidities. A total of seven papers, including 61 patients, documented the neurological status of the patients. Neurological complications were observed in 19.7% of the patients, consisting of increased intracranial pressure (n = 4), a tethered cord (n = 2), signs of spinal cord or cauda compression (n = 4) and abnormal neurological leg functioning (n = 3). Reduced muscle strength was generally not found (Souillet et al. 2003; Field et al. 1994), although one report described mild proximal weakness of the legs (Taylor et al. 2008).

Musculoskeletal manifestations of Hurler’s disease - prevalence

The prevalence of the main orthopaedic and radiological signs of Hurler’s disease is depicted in Table 3B. In the following section, these orthopaedic signs will be addressed separately.

Spine

Cervical involvement was frequently reported in Hurler’s disease. In particular, a failure of ossification of the odontoid process (odontoid dysplasia or hypoplasia), which was identified in 71.7% of the patients (Vellodi et al. 1997; Belani et al. 1993; Hite et al. 2000; Tandon et al. 1996). Somewhat remarkably, the odontoid dysplasia appeared to respond favourably to HSCT treatment (improvement of moderate/severe to mild dysplasia in 10 patients) (Hite et al. 2000; Tandon et al. 1996). Soft tissue depositions around the odontoid process were found in 85.7% of the patients, and 31.6% showed hypertrophy of the longitudinal ligaments (Weisstein et al. 2004; Kachur and Del Maestro 2000; Vellodi et al. 1997; Hite et al. 2000; Tandon et al. 1996). These cervical manifestations may result in potentially life-threatening atlantoaxial instability and spinal cord compression. Yet, in the Hurler population these symptoms were relatively rare. Atlantoaxial instability, based on flexion-extension X-rays, was identified in 20% of the patients (Souillet et al. 2003; Weisstein et al. 2004; Vellodi et al. 1997; Belani et al. 1993; Tandon et al. 1996). Cervical spinal cord compression, predominantly based on MRI imaging, was observed in only 3.4% (2 cases) (Kachur and Del Maestro 2000; Vellodi et al. 1997; Belani et al. 1993; Hite et al. 2000; Tandon et al. 1996). One of the other key features of spinal involvement in Hurler’s disease is the thoracolumbar kyphosis or gibbus deformity, which was observed in 81% of the patients (see also Table 3B). The thoracolumbar kyphosis usually develops at the level of L1-L2, and has been observed as early as birth (Cleary and Wraith 1995; Dusing et al. 2005). Failure of ossification of the anterior superior aspect of the vertebral body, i.e. beaking, was observed in 93.3% of the patients (Table 3B). Spondylolisthesis was frequently observed as well, with thinning and elongation of the pedicles, hypoplasia of the facet joints and scalloping of the posterior border of the vertebrae (Weisstein et al. 2004; Tandon et al. 1996). Only two studies reported disc space narrowing (three affected patients, prevalence 30%). Thoracolumbar spinal cord compression was also rare and documented for two patients (prevalence 3.4%) (Weisstein et al. 2004; Tandon et al. 1996). Although not as common as kyphosis, scoliosis was relatively common in Hurler patients as well (prevalence 32.6%). In 53% of the scoliosis patients, scoliosis was observed in combination with kyphosis.

Hips

Another predeliction site for the failure of primary ossification in Hurler’s disease was the acetabulum, resulting in acetabular dysplasia with subsequent hip lateralisation and (sub)luxation. A total of eight articles including 67 patients addressed acetabular dysplasia, with a prevalence of 89.6%. Early arthrography consistently revealed a non-ossified cartilaginous acetabular roof, with a centrally ossified femoral head (Field et al. 1994; Taylor et al. 2008; Masterson et al. 1996), sometimes in combination with an eversion of the acetabular labrum (Masterson et al. 1996). Acetabular dysplasia was not necessarily associated with dislocation of the hip (dislocation present in 40.6% of the patients). In order to quantify the degree of acetabular dysplasia, several methods have been used. Especially for patients undergoing surgery, measures of the MEA (mean acetabular angle), CEA (centre-edge angle), and the extrusion index have been documented (Weisstein et al. 2004; Taylor et al. 2008; Masterson et al. 1996; Rebello et al. 2009). On average, MEA scores ranged from 36° pre-operatively to 20° post-operatively (n = 27 patients). In addition to acetabular dysplasia, coxa valga and thinning of the femoral epiphysis were consistently shown as well (n = 8 (100%) and n = 42 (100%) respectively) (Field et al. 1994; Taylor et al. 2008; Masterson et al. 1996).

Knees

Failure of ossification was also observed for the lateral margin of the proximal tibial metaphysis, resulting in progressive genu valgum. A total of 103 patient reports on genu valgum showed a prevalence of 69.9%. Genu valgum was usually defined as a tibial femoral shaft angle of > 7°, with an average pre-operative angle of 17.9° (angular data for only n = 13 patients). It was predominantly identified between 2 and 5 years of age (Odunusi et al. 1999). Spontaneous regression was not observed, and progression has been associated with severe functional limitations (Field et al. 1994).

Hands

The prevalence of carpal tunnel syndrome (CTS), as identified from seven papers including 90 patients, was 63.3% (see Table 3B). The compression of the median nerve was caused by GAG deposition in the flexor retinaculum, in combination with skeletal deformities (Field et al. 1994; Van Heest et al. 1998). The development of CTS was directly associated with the age of the patients at HSCT, with each year prior to HSCT leading to a 58% increase in the risk of developing CTS (Khanna et al. 2007). The development of CTS seemed also related to the enzyme activity after HSCT, since all patients with low enzyme activity in the study of Khanna et al. developed CTS (Khanna et al. 2007). Additional limitations in hand dexterity might originate from the development of trigger fingers with flexion deformities. Reports on the prevalence of trigger fingers were limited (one paper, seven patients) with a prevalence of 57.1% (Weisstein et al. 2004).

Musculoskeletal manifestations of Hurler’s disease – orthopaedic management

Most authors recommended early surgical intervention in Hurler’s disease (Field et al. 1994; Weisstein et al. 2004; Taylor et al. 2008; Masterson et al. 1996; Odunusi et al. 1999). Yet, timing and type of surgery greatly varied. Table 3C shows the prevalence of the various surgical interventions. Table 4 summarizes their subtypes and outcomes. The average age at which Hurler patients underwent surgery is depicted in Table 5. A total of 252 reports on orthopaedic surgeries were identified, with 163 reports on treatment outcome. In the past, cardiopulmonary complications such as difficult intubation and coronary obstruction have led to several intra-operative deaths in Hurler patients (Belani et al. 1993). Improved anaesthetic techniques and increased knowledge have reduced the risk of such intra-operative complications (Ard et al. 2005; Martins et al. 2009). With regard to the orthopaedic outcome, the overall complication rate was 13.5% (22 affected patients). Yet, some treatments had complication rates up to 42.9% (thoracolumbar bracing, n = 6 / isolated femoral osteotomy, n = 6) and 56.3% (epiphyseal stapling, n = 9). Surgical failure was generally not due to non-union, as bone-healing showed normal callus formation and union (Field et al. 1994). In the following section, the subtypes and outcomes of the various surgical interventions will be further elaborated on.
Table 4

Orthopaedic treatments and outcome

Orthopaedic treatment forNumber of articlesNumber of patients operated onNumber of patients with reported outcomeComplication rateDescription of complication
Cervical instability
 O-C2 fusion331100% *Non- union (Minerva brace)
 C1-2 fusion11
 Cervical fusion, NFS11
 Total55
Cord compression
 Cervical laminectomy2220%
 Thoracal laminectomy12
 Total34
Kyphosis
 Anterior fusion2310% *
 Posterior fusion31260%
 Ant + post fusion11
 Spinal fusion, NFS93960%
 Bracing5161442.9%Progression of kyphosis
 Total1558
Genu valgum
 Epiphyseal stapling5221656.3%Staple dislodgement/Relapse after removal
 Hemi-epiphysiodesis12
 Osteotomy11
 Surgery, NFS126
 Total951
Hip dysplasia
 Isolated femoral osteotomy5161442.9%No acetabular remodelling
 Isolated pelvic osteotomy4880%
 Femoral + pelvic osteotomy519170%
 Surgery, NFS239
 Total1546
Carpal tunnel syndrome
 Soft tissue release1380701.4%No improvement of NCV
 Trigger digits
 Soft tissue release31080% 
 Overall total6325216313.5%

NFS = not further specified, NCV = nerve conduction velocity

* Note that these percentages are based on a single patient report

Table 5

Average age of Hurler patients at surgery

SurgeryAverage age at surgery (years)Age range across studies (years)Total number of operated patients with age reference
Cervical fusion9.3[7–12]3
Spinal cord decompression8[8]1
Thoracolumbar spinal fusion5.9[3.5-9.3]22
Epiphyseal stapling7.7[6.5-11]9
Hip containment surgery7.4[4.4-8.6]18
Carpal tunnel release5.4[3.4-9.3]57
Trigger finger release6.9[6.9]4
Orthopaedic treatments and outcome NFS = not further specified, NCV = nerve conduction velocity * Note that these percentages are based on a single patient report Average age of Hurler patients at surgery Surgical treatments for cervical instability and spinal cord compression were relatively rare in Hurler’s disease, with a prevalence of 11.1% and 17.6% respectively (see also Table 3C). In the case of cervical instability, both occiput-C2 and C1-C2 fusions were performed (see Table 4). The outcome was discussed for only one patient with a temporary non-union following an occiput-C2 fusion, due to suboptimal immobilisation after surgery (Minerva brace) (Weisstein et al. 2004). For cervical cord compression, successful laminectomies have been described. Yet, further details on the surgical technique were lacking. The orthopaedic treatment of thoracolumbar kyphosis appeared to be contentious with respect to both timing and type of intervention. For mild cases of kyphosis (i.e an angle below 40°) treatment was often postponed. Spontaneous improvement of mild kyphosis was observed in 15.2% of the patients (7 cases) (Weisstein et al. 2004; Staba et al. 2004). In addition, 21 cases of stable mild kyphosis were described (Souillet et al. 2003; Weisstein et al. 2004; Taylor et al. 2008; Staba et al. 2004). It must be mentioned, however, that follow-up periods for these patients did not extend into adolescence. In the case of progression or anticipated progression of kyphosis, some authors have attempted bracing (Souillet et al. 2003; Guffon et al. 1998; Taylor et al. 2008; Tandon et al. 1996). The outcome of bracing was variable, with ongoing progression of the kyphotic angle in 42.9% of the patients (six cases, see also Table 4). When the kyphotic angle progressed, surgical intervention was often required. The pre-operative Cobbs angle was on average 58.8° (angular data for only 4 patients). Furthermore, spinal cord compression, as observed in two cases, was a clear indication for surgery. Spinal fusion was performed in 32.4% of the patients, with an average follow-up duration of 86 months after HSCT (see Table 3C). The average age at spinal fusion was 5.9 years (see Table 5). For the surgical correction of kyphosis, both anterior and posterior short segment fusions were described, as well as their combination. As appears from Table 4, no adverse outcomes were reported for any of the techniques. Hip containment surgery as a treatment for hip dysplasia was common in Hurler patients (prevalence 45.5%, see Table 3C). The average age at surgery was 7.4 years (see Table 4 and 5). Several techniques have been attempted, such as an isolated femoral osteotomy, an isolated pelvic osteotomy and a combination of both techniques. As is shown in Table 4, isolated femoral osteotomies have resulted in a large percentage of failure (42.9%, n = 6) due to the absence of acetabular remodelling after surgery, requiring revision surgery (Field et al. 1994; Vellodi et al. 1997; Taylor et al. 2008). Therefore, a combination of a pelvic and femoral osteotomy was attempted instead, in 19 patients. The latter technique showed good results, with no reported adverse outcomes (Souillet et al. 2003; Weisstein et al. 2004; Taylor et al. 2008; Masterson et al. 1996). More recently, it has been shown that an isolated pelvic osteotomy without an additional femoral osteotomy, performed in 8 patients, was sufficient to contain proper femoral head coverage as well (Ringden et al. 2006; Weisstein et al. 2004; Taylor et al. 2008; Masterson et al. 1996). Genu valgum usually occurred between 2 and 5 years of age (Odunusi et al. 1999). Since spontaneous improvement was generally not observed, a surgical correction was carried out in a considerable amount of patients (36.4%, see Table 3C). The most common type of surgery was a temporary hemi-epiphysiodesis by medial epiphyseal stapling (Table 4), performed at an average age of 7.7 years (Table 5). Complications were reported for 56.3% of the patients (n = 9) (Taylor et al. 2008; Odunusi et al. 1999). The majority of adverse outcomes were related to the dislodgement of staples due to the use of suboptimal materials (barbed stainless steel), rather than by MPS I disease characteristics. Consequently, no complications have been described after the introduction of new materials (barbed vitallium staples) and the 8-plate (Taylor et al. 2008; Odunusi et al. 1999). Genu valgum was also corrected by a permanent hemi-epiphysiodesis in two patients. Since the outcome of this technique largely depends on the (unpredictable) appendicular growth of Hurler patients after surgery, this technique has become obsolete. Surgical release of the carpal tunnel, with or without additional tenosynovectomy of the flexor retinaculum, was the most often reported musculoskeletal intervention in Hurler patients (80 patient reports, Table 4; prevalence of 56%, Table 3C). A total of 70 patient reports on the outcome of surgical release for CTS were identified (see Table 4). Following surgery, muscle strength and EMG findings considerably improved. Although these beneficial effects have even been described for patients with already severe nerve compression, surgical release presumably elicits better results if done early (Van Heest et al. 1998). A lack of EMG improvements following surgery was reported only once (1.4% of the cases (Vellodi et al. 1997)). Trigger fingers were reported less frequently, with only ten descriptions of a surgical release in the current literature (see Table 4). All trigger finger releases were performed in conjunction with a CTS release. The techniques used, were a resection of the A-1 with or without the A-3 pulley, sometimes with an additional partial flexor digitorum superficialis tendon resection (Van Heest et al. 1998). The outcome was generally good, with no recurrences and improved digital flexion and hand dexterity (Van Heest et al. 1998).

Discussion and conclusion

The aim of the current study was to systematically review the developmental and orthopaedic implications of Hurler’s disease after treatment with HSCT. A considerable number of papers (32) with a total of 399 relevant patient reports were identified. Among these papers were only few prospective studies (n = 3) and no comparative studies. This has led to great variability in the scoring methods used, and carries the risk of a reporting bias. Another serious limitation of the currently published material was the relatively short follow-up period (on average 73.3 months after HSCT). Consequently, long term perspectives can not be given. Furthermore, the executed subgroup analyses were based on varying sample sizes, ranging from 7–170 patients. Nevertheless, the quantification of the prevalence and treatment of the various musculoskeletal complications, as currently given, may enhance the insights in the orthopaedic treatment of Hurler’s disease. The most frequently reported musculoskeletal manifestations of Hurler’s disease after HSCT were odontoid hypoplasia, thoracolumbar kyphosis, genu valgum, hip dysplasia and carpal tunnel syndrome. Motor functioning was further compromised by reduced joint mobility, hand dexterity, motor skills, longitudinal growth, and neurological comorbidities. Although the positive effects of HSCT on the musculoskeletal manifestations of Hurler’s disease were limited, improvements in joint mobility, motor skills, odontoid dysplasia, carpal tunnel syndrome and longitudinal growth were identified (Field et al. 1994; Hugh-Jones 1986; Weisstein et al. 2004; Fleming et al. 1998; Guffon et al. 1998; Hite et al. 2000). The improvements in joint mobility have been attributed to a reduction in GAG accumulation in the relatively well vascularised synovium, following the availability of donor enzyme in the blood (Breider et al. 1989). The improved joint mobility in addition to overall improvements in neuro-cognitive development might, in turn, explain the improved gross and fine motor skills of treated Hurler patients (Peters and Steward 2003). The etiology behind the improvement of the odontoid process deserves further attention, as it appears to be the only responsive endochondral bone (Hite et al. 2000; Tandon et al. 1996). With regard to the positive effects of HSCT treatment, early timing seems favourable (Souillet et al. 2003; Bjoraker et al. 2006; Polgreen et al. 2008; Vellodi et al. 1997; Hite et al. 2000; Khanna et al. 2007). However, even early treatment cannot prevent dysostosis multiplex, presumably because many ossification defects have already developed prior to HSCT treatment. For example, kyphosis and hip dysplasia often appear at birth (Cleary and Wraith 1995; Ringden et al. 2006; Dusing et al. 2005; Malm et al. 2008a). Besides insufficient GAG clearance, further progression of the musculoskeletal abnormalities may be due to early irreversible changes both in the growth plate and the tendoligamentous complex responsible for load transfer and stability. Although the natural course of the musculoskeletal manifestations of Hurler’s disease after HSCT remains largely unknown, an active approach towards the orthopaedic management of these patients seems warranted, due to the irreversible and progressive nature of their deficiencies. Since various surgeries are often performed in the first decade of life, a combination of surgeries, for example of the hip and knee, is advocated (Odunusi et al. 1999). Unfortunately, prospective data on treatment outcome were lacking, making it impossible to determine possibly associated factors such as age, degree of deformity and weight bearing status at the time of treatment. Nevertheless, some general recommendations regarding the orthopaedic management and follow-up of Hurler patients may be formulated based on the currently published literature. Cervical spine abnormalities are a major concern, since they might result in potentially life-threatening atlantoaxial instability and spinal cord compression, as has been frequently described in mucopolysaccharidosis type IV (MPS IV, Morquio’s disease) and type VI (MPS VI, Maroteaux-Lamy) (Hughes et al. 1997; Thorne et al. 2001). In the Hurler population these symptoms were relatively rare. One of the reasons might be that odontoid dysplasia responded favourably to HSCT treatment (Hite et al. 2000; Tandon et al. 1996). Nevertheless, annual follow-up with MRI imaging should be considered. In order to treat atlantoaxial instability, it is currently not clear whether occipito-cervical fusions should be favoured above C1-C2 fusions. Regarding the thoracolumbar kyphosis, various hypotheses on the pathogenesis have been posted. Swischuk (1970) suggested that it resulted from a combination of poor muscle tone, altered weight-bearing forces, growth abnormalities and disc herniation (Swischuk 1970). More recent findings point towards an important role of failure of ossification of the anterior superior aspect of the vertebral body (Field et al. 1994; Weisstein et al. 2004; Tandon et al. 1996). Bracing therapy might be considered especially in patients who are too young for surgery (Tandon et al. 1996; White and Harmatz 2010). Yet, the effectiveness remains largely unknown due to limited follow-up data and lack of information on the natural course of kyphosis in Hurler’s disease. In the current literature, surgical intervention for progressive kyphosis was performed at a relatively young age (5.9 years). The decision to surgically intervene largely depended on the angle of kyphosis and the related risk of progression. The average pre-operative Cobbs angle of the Hurler patients (58.8°) was consistent with general guidelines for spinal fusion (Cobbs angle exceeding 60°) (Arlet and Schlenzka 2005). Both anterior and posterior short segment fusions might be considered. Although no adverse outcomes were reported for any of the techniques, personal communications imply that posterior fusion alone may lead to failure and the need of re-operation (White and Harmatz 2010). Clinical experience with anterior fusion, in contrast, seems promising, with no failures in a period of 10 years (personal communication with Dr. H. Noordeen, Great Ormond Street Hospital for Children, London, UK). Hip dysplasia was found in the majority of Hurler patients. Yet, it should be noticed that the femoral head appeared well contained within the non-ossified lateral acetabular roof in many (Field et al. 1994; Taylor et al. 2008; Masterson et al. 1996). Nevertheless, nearly half of the patients underwent hip containment surgery. A typical feature of Hurler’s disease appeared to be the failure of acetabular remodelling following an isolated femoral osteotomy. Consequently, an osteotomy of the pelvis (with or without additional femoral osteotomy) is favoured above an isolated femoral osteotomy in Hurler patients. Progressive genu valgum occurred in the majority of patients and should be treated surgically because of the disabling consequences. Genu valgum was often treated by a temporary hemi-epiphyseodesis in the form of medial epiphyseal stapling. In children under 6 years, stapling as well as the 8-plate are difficult due to the small size of the epiphysis. In contrast, epiphyseal stapling may no longer be sufficient if the angular deformity of the knee is too large (Odunusi et al. 1999). Consequently, most patients are treated between 6–8 years of age. With respect to surgical intervention, a large percentage of adverse outcomes was observed due to the use of a suboptimal materials. After the introduction of new materials, adverse outcomes were no longer observed (Taylor et al. 2008; Odunusi et al. 1999). With respect to carpal tunnel syndrome, an aggressive approach seems warranted. Early recognition is important, since surgical release can prevent adverse outcomes with muscle wasting, flexion contractures of the fingers, secondary bony changes and subsequent reduction in hand dexterity (Field et al. 1994; Souillet et al. 2003; Weisstein et al. 2004; Guffon et al. 1998; Vellodi et al. 1997; Van Heest et al. 1998; Khanna et al. 2007; Van Meir and De Smet 2005; Bona et al. 1994). Because classical symptoms such as numbness, tingling and nocturnal pain are often lacking (Van Heest et al. 1998), annual EMG testing is advisable. When a soft tissue release for CTS is performed, intra-operative inspection of the tendons of the fingers is indicated. To conclude, stem cell transplantation has yielded enormous improvements in the therapy of Hurler’s disease and patients are now surviving into adulthood. In order to benefit optimally from HSCT treatment, early timing is favourable. Consequently, the diagnostic delay should be reduced below the currently reported 9 months (Cleary and Wraith 1995). Since the skeletal abnormalities (especially the thoracolumbar kyphosis) account for ~ 40% of the presenting signs and are often present at birth (Cleary and Wraith 1995), orthopaedic surgeons should play an important role in earlier diagnosis. Early surgical treatment is advocated and seems warranted, due to the limited response of the skeletal abnormalities to HSCT and their progressive and irreversible nature. However, prospective studies using standardised data collection are mandatory to further optimise the orthopaedic management of these patients.
  43 in total

1.  Anesthesia for an adult with mucopolysaccharidosis I.

Authors:  John L Ard; Alex Bekker; Anthony K Frempong-Boadu
Journal:  J Clin Anesth       Date:  2005-12       Impact factor: 9.452

2.  Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single center.

Authors:  Olle Ringdén; Mats Remberger; Britt-Marie Svahn; Lisbeth Barkholt; Jonas Mattsson; Johan Aschan; Katarina Le Blanc; Britt Gustafsson; Zuzana Hassan; Brigitta Omazic; Petter Svenberg; Göran Solders; Ulrika von Döbeln; Jacek Winiarski; Per Ljungman; Gunilla Malm
Journal:  Transplantation       Date:  2006-03-15       Impact factor: 4.939

3.  The use of partially HLA-mismatched donors for allogeneic transplantation in patients with mucopolysaccharidosis-I.

Authors:  D R Fleming; P J Henslee-Downey; G Ciocci; E H Romond; E Marciniak; R K Munn; J S Thompson
Journal:  Pediatr Transplant       Date:  1998-11

4.  Long-term outcomes of adaptive functions for children with mucopolysaccharidosis I (Hurler syndrome) treated with hematopoietic stem cell transplantation.

Authors:  Kendra J Bjoraker; Kathleen Delaney; Charles Peters; William Krivit; Elsa G Shapiro
Journal:  J Dev Behav Pediatr       Date:  2006-08       Impact factor: 2.225

5.  The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with Mucopolysaccharidosis Type I.

Authors:  Gregory M Pastores; Pamela Arn; Michael Beck; Joe T R Clarke; Nathalie Guffon; Paige Kaplan; Joseph Muenzer; Denise Y J Norato; Elsa Shapiro; Janet Thomas; David Viskochil; J Edmond Wraith
Journal:  Mol Genet Metab       Date:  2007-03-02       Impact factor: 4.797

6.  Carpal tunnel syndrome in children.

Authors:  Nathalie Van Meir; Luc De Smet
Journal:  J Pediatr Orthop B       Date:  2005-01       Impact factor: 1.041

7.  Bone-marrow transplantation in Hurler's syndrome. Effect on skeletal development.

Authors:  R E Field; J A Buchanan; M G Copplemans; P M Aichroth
Journal:  J Bone Joint Surg Br       Date:  1994-11

Review 8.  Carpal tunnel syndrome in Mucopolysaccharidoses. A report of four cases in child.

Authors:  I Bona; C Vial; P Brunet; J C Couturier; M Girard-Madoux; B Bady; P Guibaud
Journal:  Electromyogr Clin Neurophysiol       Date:  1994-12

9.  Follow-up of nine patients with Hurler syndrome after bone marrow transplantation.

Authors:  N Guffon; G Souillet; I Maire; J Straczek; P Guibaud
Journal:  J Pediatr       Date:  1998-07       Impact factor: 4.406

10.  Short-term growth hormone treatment in children with Hurler syndrome after hematopoietic cell transplantation.

Authors:  L E Polgreen; M Plog; J D Schwender; J Tolar; W Thomas; P J Orchard; B S Miller; A Petryk
Journal:  Bone Marrow Transplant       Date:  2009-03-02       Impact factor: 5.483

View more
  28 in total

1.  Prevalence and development of orthopaedic symptoms in the dutch hurler patient population after haematopoietic stem cell transplantation.

Authors:  F J Stoop; M C Kruyt; M H van der Linden; R J B Sakkers; P M van Hasselt; R M C Castelein
Journal:  JIMD Rep       Date:  2012-09-19

2.  The effect of neonatal gene therapy on skeletal manifestations in mucopolysaccharidosis VII dogs after a decade.

Authors:  Elizabeth M Xing; Van W Knox; Patricia A O'Donnell; Tracey Sikura; Yuli Liu; Susan Wu; Margret L Casal; Mark E Haskins; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2013-04-06       Impact factor: 4.797

3.  Hurler syndrome: orofacial, dental, and skeletal findings of a case.

Authors:  Arpita Rai Thakur; Venkatesh G Naikmasur; Atul Sattur
Journal:  Skeletal Radiol       Date:  2014-08-20       Impact factor: 2.199

4.  Intra-articular enzyme replacement therapy with rhIDUA is safe, well-tolerated, and reduces articular GAG storage in the canine model of mucopolysaccharidosis type I.

Authors:  Raymond Y Wang; Afshin Aminian; Michael F McEntee; Shih-Hsin Kan; Calogera M Simonaro; William C Lamanna; Roger Lawrence; N Matthew Ellinwood; Catalina Guerra; Steven Q Le; Patricia I Dickson; Jeffrey D Esko
Journal:  Mol Genet Metab       Date:  2014-06-06       Impact factor: 4.797

Review 5.  Hurdles in treating Hurler disease: potential routes to achieve a "real" cure.

Authors:  Brigitte T A van den Broek; Jaap van Doorn; Charlotte V Hegeman; Stefan Nierkens; Caroline A Lindemans; Nanda Verhoeven-Duif; Jaap Jan Boelens; Peter M van Hasselt
Journal:  Blood Adv       Date:  2020-06-23

6.  The effect of Tlr4 and/or C3 deficiency and of neonatal gene therapy on skeletal disease in mucopolysaccharidosis VII mice.

Authors:  Elizabeth M Xing; Susan Wu; Katherine P Ponder
Journal:  Mol Genet Metab       Date:  2014-12-19       Impact factor: 4.797

7.  Surgical management of thoracolumbar kyphosis in mucopolysaccharidosis type 1 in a reference center.

Authors:  Kariman Abelin Genevois; Christophe Garin; Federico Solla; Nathalie Guffon; Rémi Kohler
Journal:  J Inherit Metab Dis       Date:  2013-06-29       Impact factor: 4.982

Review 8.  Pathogenesis and treatment of spine disease in the mucopolysaccharidoses.

Authors:  Sun H Peck; Margret L Casal; Neil R Malhotra; Can Ficicioglu; Lachlan J Smith
Journal:  Mol Genet Metab       Date:  2016-06-04       Impact factor: 4.797

9.  Genistein increases glycosaminoglycan levels in mucopolysaccharidosis type I cell models.

Authors:  Sandra D K Kingma; Tom Wagemans; Lodewijk IJlst; Frits A Wijburg; Naomi van Vlies
Journal:  J Inherit Metab Dis       Date:  2014-04-04       Impact factor: 4.982

10.  Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I.

Authors:  Alice Pievani; Isabella Azario; Laura Antolini; Tsutomu Shimada; Pravin Patel; Cristina Remoli; Benedetta Rambaldi; Maria Grazia Valsecchi; Mara Riminucci; Andrea Biondi; Shunji Tomatsu; Marta Serafini
Journal:  Blood       Date:  2014-10-08       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.